Please assess the completion status of the following clinical trial:

Trial Title: Long-term Extension Study of TAK-438 for the Prevention of Recurrent Gastric or Duodenal Ulcers During Therapy of Low-dose Aspirin

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE3
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~1. Participants who require continuous low-dose aspirin therapy during the treatment period with the study drug~2. Participants who have completed the preceding study~3. Outpatient (including inpatient for examinations)~Exclusion Criteria:~1. Participants deemed to be ineligible to participate in the study by the principal investigator or investigator due to the occurrence of adverse events in the preceding study~2. Participants who are scheduled to change the type and dosage regimen of low-dose aspirin~3. Participants with ulcers or bleeding in stomach or duodenum, endoscopically confirmed during the preceding study~4. Participants with small intestine bleeding, large intestine bleeding, or gastrointestinal bleeding of unknown etiology~5. Participants who have a history of surgery which affects gastric acid secretion (e.g., resection of upper gastrointestinal tract, vagotomy) or who are scheduled to undergo such surgery~6. Participants with a previous or current history of Zollinger-Ellison syndrome, or other gastric acid hypersecretion disorders~7. Participants with a previous or current history of aspirin-induced asthma

- Gender: ALL
- Minimum Age: 20 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- TAK-438 10 mg QD (Type: EXPERIMENTAL): None
- TAK-438 20 mg QD (Type: EXPERIMENTAL): None
- AG-1749 15 mg QD (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).